希玛医疗控股有限公司（股票代码：03309）于2026年9月4日发布公告，披露当日于香港联交所场内回购140,000股普通股，占公司回购前已发行股本约0.0116%。此次回购价格区间在每股0.855港元至0.875港元之间，合计付出金额共120,300港元（约12.03万港元）。
本次回购完成后，公司已发行股本由原先的1,208,930,870股降至1,208,790,870股，库藏股数量相应增加至23,552,000股，总股本仍为1,232,342,870股。根据公告，该购回授权于2026年5月20日获得通过，授权范围为123,234,287股。截至目前，累计已回购140,000股，占授权总数约0.0114%。
公司确认本次股份购回已遵守香港联合交易所有限公司的上市规则以及相关法规。公告由公司秘书陈华平签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.